FDA Panel to Discuss Abuse Potential of Cough Medicine
MedPage Today -- WASHINGTON -- An FDA advisory panel is meeting Tuesday to vote on whether to reclassify the active ingredient in more than 125 over-the-counter cough medicines as a controlled substance in order to curb abuse.